Biomarkers to predict cardiovascular disease in people living with HIV

Padraig McGettrick1, Patrick W G Mallon1,2

  • 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin.

Insights

Cardiovascular disease risk prediction in people living with HIV (PWH) is challenging. This review examines novel biomarkers for identifying PWH at risk of developing cardiovascular diseases (CVD).

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biomarker Research

Background:

  • Cardiovascular diseases (CVD) are a major cause of illness and death in people living with HIV (PWH) on antiretroviral therapy.
  • Traditional CVD risk algorithms are unreliable for PWH.
  • Identifying reliable risk predictors is crucial for this population.

Purpose of the Study:

  • To review recent research (18-24 months) on biomarkers for CVD risk in PWH.
  • To explore the potential of inflammatory markers and functional assays in CVD risk prediction.
  • To assess the clinical utility of emerging biomarkers.

Main Methods:

  • Literature review of recent studies on CVD biomarkers in PWH.
  • Analysis of research on inflammatory markers and subclinical CVD.
  • Examination of studies investigating monocyte/macrophage function in CVD pathogenesis.

Main Results:

  • Persistent associations exist between inflammatory markers and CVD in PWH.
  • Few biomarkers have demonstrated clinical utility for improving CVD risk prediction.
  • Functional assays of monocyte/macrophages show promise as predictors.

Conclusions:

  • While associations are noted, clinically useful biomarkers for CVD risk in PWH are limited.
  • Larger population studies are required to validate the utility of biomarkers.
  • Further research is needed to refine CVD risk prediction models for PWH.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
255
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
390
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
473
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
333
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
509
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
106